CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,250,000 | -69.0% | 247,450 | -62.5% | 0.01% | -73.5% |
| Q1 2018 | $4,030,000 | -14.1% | 660,714 | 0.0% | 0.03% | -17.1% |
| Q4 2017 | $4,691,000 | +472.1% | 660,714 | +407.7% | 0.04% | +485.7% |
| Q2 2017 | $820,000 | -23.6% | 130,129 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $1,074,000 | -51.1% | 130,129 | -50.0% | 0.01% | -59.1% |
| Q4 2016 | $2,198,000 | – | 260,129 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
| ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
| AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
| Platform Technology Partners | 60,000 | $75,000 | 0.04% |
| PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
| HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
| Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
| Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
| Aries Wealth Management | 23,400 | $33,000 | 0.02% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |